Envista Holdings Corp
General ticker "NVST" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.3B (TTM average)
Envista Holdings Corp follows the US Stock Market performance with the rate: 67.3%.
Estimated limits based on current volatility of 1.6%: low 20.28$, high 20.93$
Factors to consider:
- Total employees count: 12300 as of 2024
- US accounted for 47.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Economic downturns and volatility, Supply chain disruptions, Regulatory and compliance, Geopolitical risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [14.89$, 28.34$]
- 2025-12-31 to 2026-12-31 estimated range: [15.18$, 28.96$]
Financial Metrics affecting the NVST estimates:
- Positive: with PPE of 25.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -1.49 <= -0.15
- Positive: -4.48 < Investing cash flow per share per price, % of -1.68
- Positive: 41.86 < Shareholder equity ratio, % of 54.85 <= 63.39
- Positive: 6.82 < Operating cash flow per share per price, % of 10.37
Short-term NVST quotes
Long-term NVST plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,569.10MM | $2,566.50MM | $2,510.60MM |
| Operating Expenses | $2,249.90MM | $2,535.00MM | $3,548.80MM |
| Operating Income | $319.20MM | $31.50MM | $-1,038.20MM |
| Non-Operating Income | $-35.30MM | $-86.40MM | $-46.50MM |
| Interest Expense | $38.40MM | $63.40MM | $46.40MM |
| R&D Expense | $100.10MM | $93.80MM | $99.10MM |
| Income(Loss) | $283.90MM | $-54.90MM | $-1,084.70MM |
| Taxes | $45.90MM | $45.30MM | $33.90MM |
| Other Income(Loss) | $5.10MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $238.00MM | $-100.20MM | $-1,118.60MM |
| Stockholders Equity | $4,206.90MM | $4,173.90MM | $2,934.80MM |
| Inventory | $300.80MM | $258.80MM | $241.00MM |
| Assets | $6,587.00MM | $6,605.10MM | $5,350.50MM |
| Operating Cash Flow | $182.70MM | $275.70MM | $336.50MM |
| Capital expenditure | $75.70MM | $58.20MM | $33.80MM |
| Investing Cash Flow | $-657.30MM | $-62.40MM | $-54.60MM |
| Financing Cash Flow | $12.50MM | $118.90MM | $-103.70MM |
| Earnings Per Share** | $1.46 | $-0.60 | $-6.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.